Pharmaceuticals
Pfizer secures China nod for obesity drug as generics loom
Pfizer now enters a field dominated by multinational rivals
Gilead to buy US biotech Arcellx for up to US$7.8 billion
The US drugmaker seeks to boost its cancer drug pipeline
Walgreens cuts hundreds of jobs after private equity buyout
The pharmacy chain is also slowing down its store closures
Trump unveils TrumpRx discounted drugs website
The website is targeted at consumers looking to buy drugs without using insurance
India to spend 100 billion rupees to make biopharma production hub
The funding will be directed towards the research and production of biologics and biosimilar medicines
US FDA launches programme to boost domestic drug manufacturing
It’s in line with President Donald Trump’s executive order in May to shift manufacturing of drugs to the US
How China rewrote the rules of drug innovation
In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory velocity becomes a binding constraint
CEO of Salonpas maker seeks to take the 450 billion yen drug firm private
The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ages
Pfizer forecasts 2026 profit below expectations on lower Covid product sales
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences
